Ellevest, Inc. Alkermes Plc. Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$22.0 - $31.87 $396 - $573	-18 Reduced 21.43%	66 $1,000
Q1 2022 Apr 19, 2022	BUY	$23.07 - $27.99 $415 - $503	18 Added 27.27%	84 $2,000
Q4 2021 Jan 24, 2022	SELL	$21.47 - $32.08 $85 - $128	-4 Reduced 5.71%	66 $2,000
Q2 2021 Jul 13, 2021	BUY	$18.78 - $25.15 $1,314 - $1,760	70 New	70 $2,000
Q2 2020 Jul 06, 2020	SELL	$13.31 - $19.41 $505 - $737	-38 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$13.06 - $21.24 $300 - $488	-23 Reduced 37.7%	38 $1,000
Q4 2019 Feb 05, 2020	BUY	$17.29 - $21.74 $1,054 - $1,326	61 New	61 $1,000

359

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.18B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.